Abstract
Abstract Ca-alginate-chitosan based microcapsules were prepared and used for the controlled release of imidacloprid larvacide against Aedes aegypti larvae. Imidacloprid encapsulation was evidenced through HPLC and FTIR analysis. Imidacloprid loading varied from 2.79% to 6.85% with encapsulation efficiency of up to 39.16%. TGA and DSC studies revealed good thermal stability and compatibility between the polymers and imidacloprid. X-ray diffractometry (XRD) results indicated a molecular level dispersion of imidacloprid in the polymer matrix. The in vitro release profiles of imidacloprid could be controlled by modifying the formulation, pH, or temperature. The imidacloprid release kinetics fit the Korsmeyer–Peppas model and follows the anomalous transport profile. The mechanism of imidacloprid release was proposed. In vivo release studies demonstrated that a dose of 6.11 mg/L is sufficient to destroy Aedes aegypti larvae. It was predicted that 50% and 100% larvae mortality are achieved for 369 and 141 days respectively.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
